Astera Labs Director Sells $2M in Shares Under Planned Trading Program
Director Manuel Alba of Astera Labs (ALAB) reported multiple stock sales executed on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from May 2024.
Rhea-AI Filing Summary
Director Manuel Alba of Astera Labs (ALAB) reported multiple stock sales executed on June 20, 2025, through a pre-established Rule 10b5-1 trading plan from May 2024. The transactions involved:
- Casa Alameda 2007 LLC sold 3,709 shares at weighted average prices between $100.63-101.25 per share
- Alba Trust disposed of 16,441 shares at similar price ranges of $100.63-101.25 per share
Following these transactions, Alba maintains beneficial ownership of: 432,854 shares through Casa Alameda LLC, 1,967,757 shares via Alba Trust, 5,000 shares through spouse, and 2,351 shares directly. The filing includes disclaimers regarding beneficial ownership of trust and LLC holdings, limiting claims to Alba's pecuniary interests. All sales were executed according to the automated trading plan, demonstrating planned portfolio management rather than reactive selling.
Positive
- None.
Negative
- Director Manuel Alba executed planned sales of approximately 20,150 shares worth over $2 million through two investment vehicles (Casa Alameda 2007, LLC and Alba Trust) at prices between $100-101.73 per share
Insider Trade Summary
Net Seller: 20,150 shares
Net Sell
6 txns
Insider
ALBA MANUEL
Role
Director
Sold
20,150 shs ($2.03M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,467 | $100.6269 | $248K |
| Sale | Common Stock | 1,242 | $101.2519 | $126K |
| Sale | Common Stock | 10,934 | $100.6271 | $1.10M |
| Sale | Common Stock | 5,507 | $101.252 | $558K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 432,854 shares (Indirect, By Casa Alameda 2007, LLC);
Common Stock — 1,967,757 shares (Indirect, By Alba Trust);
Common Stock — 5,000 shares (Indirect, By spouse);
Common Stock — 2,351 shares (Direct)
Footnotes (5)
- F1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2024.
- F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.0000 to $100.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. These shares are owned directly by Casa Alameda 2007, LLC, of which the Reporting Person is a manager. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.0000 to $101.7300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. These shares are owned directly by Manuel Alba-Marquez in trust for Alba 2003 Living Trust (the "Alba Trust"), of which the Reporting Person and his spouse are co-trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What was the selling price range for ALAB stock in Director Alba's transactions?
The shares were sold in two price ranges: 1) Between $100.00 and $100.99 per share, with a weighted average price of $100.6269-$100.6271, and 2) Between $101.00 and $101.73 per share, with a weighted average price of $101.2519-$101.2520.
Was ALAB Director Manuel Alba's stock sale pre-planned?
Yes, the sales were pre-planned and executed automatically pursuant to a Rule 10b5-1 trading plan that Alba adopted on May 31, 2024, approximately one year before the transactions.
What positions does Manuel Alba hold at ALAB?
According to the Form 4 filing, Manuel Alba serves as a Director of Astera Labs, Inc. (ALAB). The filing indicates he is not an officer or 10% owner of the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
